Fulgent Genetics, Inc. (FLGT)

Fulgent Genetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	55.14	97.47	79.51	164.89	87.43
Short-Term Investments	202.96	326.68	446.73	285.61	211.94
Cash & Short-Term Investments	258.11	424.15	526.24	450.5	299.37
Cash Growth	-39.15%	-19.40%	16.81%	50.48%	958.99%
Accounts Receivable	69.02	51.13	52.75	139.15	185.24
Other Receivables	8.01	6.31	22.36	4.15	18.83
Receivables	77.03	57.45	75.11	143.3	204.06
Prepaid Expenses	6.63	7.74	6.81	4.24	3.68
Other Current Assets	11.81	18.5	19.71	13.92	16.51
Total Current Assets	353.57	507.85	627.87	611.96	523.62
Property, Plant & Equipment	111.72	95.62	98.92	71.16	41.03
Long-Term Investments	595.28	444.01	339.03	507.01	132.5
Goodwill	22.06	22.06	143.03	50.9	-
Other Intangible Assets	134.98	143.05	150.64	35.91	-
Long-Term Deferred Tax Assets	-	-	3.5	0.76	1.63
Other Long-Term Assets	2.37	22.75	23.05	1.02	1.69
Total Assets	1,220	1,235	1,386	1,279	700.46
Accounts Payable	18.36	15.36	23.09	20.49	26.39
Accrued Expenses	22.44	26.24	17.91	15.52	8.54
Short-Term Debt	-	-	15	21.28	15.02
Current Portion of Long-Term Debt	0.41	1.18	5.64	-	-
Current Portion of Leases	1.84	4.5	7.08	2.17	-
Current Income Taxes Payable	-	-	-	0.79	53.32
Current Unearned Revenue	2.23	2.87	3.2	14.57	26.58
Other Current Liabilities	27.61	22.86	16.2	30.49	0.27
Total Current Liabilities	72.9	73.02	88.11	105.31	130.12
Long-Term Debt	2.49	2.96	-	-	-
Long-Term Leases	4.48	7.91	10.61	6.74	0.57
Long-Term Deferred Tax Liabilities	6.37	7.96	-	-	-
Other Long-Term Liabilities	4.56	10.19	17.46	0.79	0.39
Total Liabilities	90.81	102.04	116.18	112.84	131.07
Common Stock	0	0	0	0	0
Additional Paid-In Capital	543.13	501.72	486.59	501.91	418.07
Retained Earnings	590.47	633.18	801	657.6	150.88
Comprehensive Income & Other	-0.37	1.21	-20.9	-0.76	0.44
Total Common Equity	1,133	1,136	1,267	1,159	569.39
Minority Interest	-4.07	-2.82	3.19	7.13	-
Shareholders' Equity	1,129	1,133	1,270	1,166	569.39
Total Liabilities & Equity	1,220	1,235	1,386	1,279	700.46
Total Debt	9.23	16.56	38.33	30.2	15.59
Net Cash (Debt)	819.23	831.17	814.56	905.35	416.28
Net Cash Growth	-1.44%	2.04%	-10.03%	117.48%	516.35%
Net Cash Per Share	27.10	27.91	26.31	29.23	17.30
Filing Date Shares Outstanding	30.83	29.78	29.52	30.25	28.87
Total Common Shares Outstanding	30.84	29.65	29.44	30.16	28.18
Working Capital	280.67	434.83	539.77	506.65	393.5
Book Value Per Share	36.74	38.31	43.03	38.42	20.21
Tangible Book Value	976.2	970.99	973.02	1,072	569.39
Tangible Book Value Per Share	31.65	32.75	33.05	35.54	20.21
Land	17.35	8.8	7.5	7.5	7.5
Buildings	49.61	17.53	12.6	10.67	7.44
Machinery	76.07	73.65	71.97	51.22	31.6
Leasehold Improvements	3.32	11.22	11.8	4	1.58

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q